Trying huperzine A put me on the path to being diagnosed with MG
Columnist Shawna Barnes was on the hunt for a clue to her MG symptoms when a late-night search on the internet brought her to huperzine A.| Myasthenia Gravis News
The first recommendation anyone gives you when you’re diagnosed with a chronic illness is always the same: rest. And for the past five years, I fully believed it. I told […] The post Gently testing the limits of my MG with more activity appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
An analysis of the Swedish MG registry suggests that adults with myasthenia gravis (MG) have an impaired quality of life, even when they show low disease activity. Muscle weakness affecting […] The post Myasthenia gravis affects quality of life, even when symptoms are mild appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
A new Phase 3 clinical trial testing Kyverna Therapeutics’ cell therapy candidate KYV-101 in people with myasthenia gravis (MG) — a study the developer says “supports [a] clear and rapid path […] The post ‘FDA-aligned’ trial of KYV-101 for MG likely to start enrolling this year appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
I don’t enjoy going outside now as much as I did in my youth. I’m a homebody and I like it. This transition made me think of my twin, Aaron, […] The post My twin with MG takes several precautions before going outside appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
I haven’t had a disease flare-up recently or a full physical and mental breakdown. Still, this year has been a roller coaster for me. Each month seems to follow a […] The post Stress is the real enemy when living with myasthenia gravis appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Living with myasthenia gravis (MG) doesn’t always involve big, cinematic moments of triumph. Instead, progress often comes in small victories. Some days, just finishing the laundry or making a grocery […] The post Small victories offer hope amid the relentless struggle with MG appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Cemdisiran, an under-the-skin injection therapy given every three months, significantly reduced disease activity in people with generalized myasthenia gravis (gMG) after six months of treatment. That’s according to data from […] The post Cemdisiran significantly eases disease activity in gMG adults appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Treatment with Vyvgart (efgartigimod alfa-fcab) helped reduce the impact of generalized myasthenia gravis (gMG) on activities of daily living among adults who tested negative for antibodies targeting the acetylcholine receptor (AChR) […] The post Vyvgart eases gMG impact on daily living in seronegative adults in trial appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Columnist Shawna Barnes was on the hunt for a clue to her MG symptoms when a late-night search on the internet brought her to huperzine A.| Myasthenia Gravis News
Tapping into PD-1/PD-L1 immune checkpoint proteins — which serve as a kind of natural off switch for an overactive immune response — might help keep myasthenia gravis (MG) under control. […] The post Study IDs possible ‘off switch’ for overactive immune response in MG appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Columnist Mark Harrington, a retired history teacher, reflects on the life of Chief Opechancanough, who led the Powhatan Confederacy.| Myasthenia Gravis News
Circulating inflammatory molecules called cytokines may be associated with a risk for developing myasthenia gravis, a recent study suggests.| Myasthenia Gravis News
Columnist Sarah Bendiff has discovered her own techniques for surviving summer, when heat makes her flare-ups more likely.| Myasthenia Gravis News
Columnist Shawna Barnes delves into pyridostigmine bromide's history and its crucial role as an MG treatment.| Myasthenia Gravis News
Treatment decisions should be collaborative, says columnist Mark Harrington, who insists on being the final arbiter in his healthcare.| Myasthenia Gravis News
Columnist Allen Francis is learning from his brother with MG how best to process anger, and it begins with not suppressing it.| Myasthenia Gravis News
Columnist Shawna Barnes is ready for some emotional separation from myasthenia gravis, so she's delivering it a breakup letter.| Myasthenia Gravis News
Columnist Allen Francis says that his twin with MG finds chewing and swallowing more difficult as they both get older.| Myasthenia Gravis News
Columnist Mark Harrington says he mourns the loss of his identity and financial stability due to the fallout from myasthenia gravis.| Myasthenia Gravis News
Gefurulimab outperformed a placebo in easing gMG symptoms in a clinical trial involving over 250 patients positive for anti-AChR antibodies.| Myasthenia Gravis News
Columnist Sarah Bendiff wants to collect as many memories as she can now, a drive that comes from a fear of being paralyzed due to MG.| Myasthenia Gravis News
The Web's Daily Resource for Myasthenia Gravis News| Myasthenia Gravis News
The anti-inflammatory therapy telitacicept for myasthenia gravis was granted orphan drug status in the EU by the European Medicines Agency.| Myasthenia Gravis News
Zilbrysq was found safe and effective in a clinical trial for generalized myasthenia gravis patients who switched from other C5 inhibitors.| Myasthenia Gravis News
Povetacicept reduced disease activity in a mouse model of MG by reducing the levels of disease-causing antibodies in the bloodstream.| Myasthenia Gravis News
Vor Bio signed an exclusive license agreement to develop and market Remegen’s telitacicept for MG outside China, Hong Kong, Macau, and Taiwan.| Myasthenia Gravis News
Thymectomy led to a long-term reduction in the levels of immune T-cells and to temporary changes in cytokine levels in MG patients.| Myasthenia Gravis News
Two women with severe, treatment-resistant MG responded well to the cancer medication blinatumomab, according to a case report.| Myasthenia Gravis News
Is myasthenia gravis actually a rare disease? Columnist Shawna Barnes addresses this common question in the MG community.| Myasthenia Gravis News
The FDA has approved once-daily zilucoplan as Zilbrysq for adults with generalized MG who are positive for antibodies targeting AChR.| Myasthenia Gravis News
Study data show long-term treatment with Zilbrysq led to sustained reductions in disease severity in generalized myasthenia gravis patients.| Myasthenia Gravis News
Columnist Shawna Barnes describes the different types of air hunger she experiences with MG, as well as their probable causes.| Myasthenia Gravis News
Exercise and physiotherapy can improve muscle strength, alleviate fatigue, and boost quality of life for people with myasthenia gravis.| Myasthenia Gravis News
Esteban holds a Master of Science in Immunology from the Instituto Politécnico Nacional in Mexico, focused on inflammation and metabolism. With five years of experience as a Medical Science Liaison, he has worked directly with physicians across a wide range of specialties, covering topics...| Myasthenia Gravis News
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Immunosuppressants, a class of medicines that broadly work to reduce immune system activity, are widely used to treat myasthenia gravis (MG).| Myasthenia Gravis News
Researchers say the case suggests Vyvgart can be an alternative drug for achieving minimal manifestation status during a myasthenic crisis.| Myasthenia Gravis News
More than half of MG patients in a study had fatigue and its severity correlated with disease worsening, crises, and delays in diagnosis.| Myasthenia Gravis News
Rituximab is an antibody-based therapy that may be used off-label in patients with certain types of myasthenia gravis.| Myasthenia Gravis News
A 64-year-old woman with dropped head syndrome was found to have a form of MG with antibodies against MuSK, and weak spine muscles.| Myasthenia Gravis News
Rituximab isn't officially approved for MG, but is used off-label when standard treatments fail, such as patients with anti-MuSK antibodies.| Myasthenia Gravis News
Columnist Shawna Barnes shares the hard-earned wisdom that would've helped her navigate life with myasthenia gravis after her diagnosis.| Myasthenia Gravis News
More than a quarter of gMG patients wait more than one year to receive an accurate diagnosis, according to study of five European countries.| Myasthenia Gravis News
Lindsey Shapiro is a science writer for Myasthenia Gravis News with a PhD in neuroscience. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
An open-label, multicenter Phase 2 clinical trial will test KYV-101 in people with refractory MG and positive for self-reactive antibodies.| Myasthenia Gravis News
Vyvgart is an approved infusion treatment for adults with generalized myasthenia gravis who are AChR-antibody positive.| Myasthenia Gravis News
Rystiggo is a myasthenia gravis treatment for adults with generalized MG. It's administered as an injection.| Myasthenia Gravis News
IImmunovant is prioritizing IMVT-1402 as its lead MG treatment candidate, with registrational clinical trials possible in the next year.| Myasthenia Gravis News
Batoclimab is an experimental antibody therapy being developed for generalized myasthenia gravis, along with other autoimmune disorders.| Myasthenia Gravis News
Columnist Shawna Barnes, who has seronegative myasthenia gravis, is happy with her treatments and sees no reason now to change them.| Myasthenia Gravis News
Getting a correct myasthenia gravis diagnosis may require a series of blood, nerve, muscle, and imaging tests.| Myasthenia Gravis News
Living with myasthenia gravis can be challenging, but the right strategies can help you manage your symptoms and ease their effects.| Myasthenia Gravis News
Fatigue linked to myasthenia gravis can affect a person’s quality of life, but there are coping strategies that can be used to minimize it.| Myasthenia Gravis News
Joana Carvalho is a managing science editor for BioNews with a PhD in biomedical sciences. She edits and fact-checks articles on a variety of rare and chronic disease topics.| Myasthenia Gravis News
Treatment with telitacicept for almost six months lessened disease activity in gMG adults positive for anti-AChR antibodies, per a study.| Myasthenia Gravis News
When symptoms of myasthenia gravis and a crisis left him so exhausted he wanted to give up, columnist Mark Harrington relied on his tenacity.| Myasthenia Gravis News
Marisa Wexler is a senior science writer for Myasthenia Gravis News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
No description.| Myasthenia Gravis News
Soliris (eculizumab) is an infusion therapy approved for treating adults with generalized myasthenia gravis.| Myasthenia Gravis News
With a little knowledge and some planning, you can learn to not only live with myasthenia gravis but to thrive.| Myasthenia Gravis News
Bionews employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, to ensure news and information is well-written, accurate, and easy to understand.| Myasthenia Gravis News
Intravenous immunoglobulin (IVIG) is a compound that consists of immune globulins (immune proteins) that are usually administered into the bloodstream, to treat patients with severe or worsening myasthenia gravis.| Myasthenia Gravis News
Vanda Pinto is a science writer for Myasthenia Gravis News with a PhD in biomedicine. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Steve Bryson is a science writer for Myasthenia Gravis News with a PhD in biochemistry. He covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
There are three main forms of myasthenia gravis, and while they differ, they all result in symptoms of muscle weakness and fatigue.| Myasthenia Gravis News
Muscle weakness and fatigue are hallmark symptoms of myasthenia gravis (MG), an autoimmune disorder. MG symptoms may come and go.| Myasthenia Gravis News
Myasthenia gravis occurs when self-reactive antibodies mistakenly attack the body's immune system, causing muscle weakness and fatigue.| Myasthenia Gravis News
Columnist Shawna Barnes shares three things she wishes she'd done differently in pursuit of a myasthenia gravis diagnosis.| Myasthenia Gravis News
Category archive page for Columns.| Myasthenia Gravis News
Margarida Maia is a science writer for Myasthenia Gravis News with a PhD in biomedical sciences. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Thymectomy removes the thymus gland, aiming to cause remission from myasthenia gravis symptoms and a decrease in the need for medications.| Myasthenia Gravis News
There is no cure for myasthenia gravis, but different treatment approaches, such as medication and surgery, are available.| Myasthenia Gravis News
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Myasthenia Gravis News
Generalized myasthenia gravis patients with mild muscle weakness saw more relief after surgery than those with moderate or severe weakness.| Myasthenia Gravis News
Plasmapheresis is a treatment for myasthenia gravis, commonly used during a myasthenic crisis and in preparation for thymectomy.| Myasthenia Gravis News
Mestinon (pyridostigmine bromide) is an oral therapy approved for the treatment of myasthenia gravis (MG).| Myasthenia Gravis News
Generalized myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness in different parts of the body.| Myasthenia Gravis News
Category archive page for News.| Myasthenia Gravis News
Remegen enrolled the first U.S. patient in a Phase 3 trial testing the safety and efficacy of telitacicept for generalized myasthenia gravis.| Myasthenia Gravis News
The anti-malaria drug dihydroartemisinin, known as DHA, showed promise for treating myasthenia gravis in a rat model of MG, per a new study.| Myasthenia Gravis News
Myasthenia gravis and summer heat are not friends, but these tactics have helped columnist Shawna Barnes reduce her heat intolerance.| Myasthenia Gravis News
Soliris effectively eased symptoms and reduced the need for other medications in adults with MG in a clinical practice setting, data show.| Myasthenia Gravis News
People with gMG with difficulty getting diagnosed or hard-to-manage disease symptoms accrue higher healthcare-related costs, per a study.| Myasthenia Gravis News
Having a thymectomy was found to significantly ease neurological symptoms in MG patients older than 65 with a thymus tumor, per a new study.| Myasthenia Gravis News
Scientists have identified a set of inflammatory molecules that could be useful as biomarkers to aid in MG diagnosis and classification.| Myasthenia Gravis News
Into-the-vein treatment with Vyvgart (efgartigimod alfa) resolved an MG crisis in a man who had failed to respond to prior treatments.| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News
